These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11847216)

  • 1. 4E-binding proteins, the suppressors of eukaryotic initiation factor 4E, are down-regulated in cells with acquired or intrinsic resistance to rapamycin.
    Dilling MB; Germain GS; Dudkin L; Jayaraman AL; Zhang X; Harwood FC; Houghton PJ
    J Biol Chem; 2002 Apr; 277(16):13907-17. PubMed ID: 11847216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mechanism of resistance to rapamycin in human cancer cells.
    Hosoi H; Dilling MB; Liu LN; Danks MK; Shikata T; Sekulic A; Abraham RT; Lawrence JC; Houghton PJ
    Mol Pharmacol; 1998 Nov; 54(5):815-24. PubMed ID: 9804616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myogenic differentiation is dependent on both the kinase function and the N-terminal sequence of mammalian target of rapamycin.
    Shu L; Zhang X; Houghton PJ
    J Biol Chem; 2002 May; 277(19):16726-32. PubMed ID: 11875068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational homeostasis: eukaryotic translation initiation factor 4E control of 4E-binding protein 1 and p70 S6 kinase activities.
    Khaleghpour K; Pyronnet S; Gingras AC; Sonenberg N
    Mol Cell Biol; 1999 Jun; 19(6):4302-10. PubMed ID: 10330171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of rapamycin sensitivity in breast cancer cells.
    Noh WC; Mondesire WH; Peng J; Jian W; Zhang H; Dong J; Mills GB; Hung MC; Meric-Bernstam F
    Clin Cancer Res; 2004 Feb; 10(3):1013-23. PubMed ID: 14871980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition.
    Dudkin L; Dilling MB; Cheshire PJ; Harwood FC; Hollingshead M; Arbuck SG; Travis R; Sausville EA; Houghton PJ
    Clin Cancer Res; 2001 Jun; 7(6):1758-64. PubMed ID: 11410517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons.
    Lekmine F; Uddin S; Sassano A; Parmar S; Brachmann SM; Majchrzak B; Sonenberg N; Hay N; Fish EN; Platanias LC
    J Biol Chem; 2003 Jul; 278(30):27772-80. PubMed ID: 12759354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E.
    Fingar DC; Salama S; Tsou C; Harlow E; Blenis J
    Genes Dev; 2002 Jun; 16(12):1472-87. PubMed ID: 12080086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism.
    Erbay E; Chen J
    J Biol Chem; 2001 Sep; 276(39):36079-82. PubMed ID: 11500483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
    Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
    Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of mRNA translation in rat cardiac myocytes by insulin involves multiple rapamycin-sensitive steps.
    Wang L; Wang X; Proud CG
    Am J Physiol Heart Circ Physiol; 2000 Apr; 278(4):H1056-68. PubMed ID: 10749698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal pathways involved in activation of p70S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6.
    Shi Y; Hsu JH; Hu L; Gera J; Lichtenstein A
    J Biol Chem; 2002 May; 277(18):15712-20. PubMed ID: 11872747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity.
    Huang S; Shu L; Easton J; Harwood FC; Germain GS; Ichijo H; Houghton PJ
    J Biol Chem; 2004 Aug; 279(35):36490-6. PubMed ID: 15218033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 4E-BP1/eIF4E ratio is a determinant for rapamycin response in esophageal cancer cells.
    Hsu HS; Lin MH; Jang YH; Kuo TT; Liu CC; Cheng TH
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):378-85. PubMed ID: 25439783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
    Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
    Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin-resistant phosphorylation of the initiation factor-4E-binding protein (4E-BP1) in v-SRC-transformed hamster fibroblasts.
    Tuhácková Z; Sovová V; Sloncová E; Proud CG
    Int J Cancer; 1999 Jun; 81(6):963-9. PubMed ID: 10362146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.
    Shi Y; Gera J; Hu L; Hsu JH; Bookstein R; Li W; Lichtenstein A
    Cancer Res; 2002 Sep; 62(17):5027-34. PubMed ID: 12208757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.
    Wang X; Beugnet A; Murakami M; Yamanaka S; Proud CG
    Mol Cell Biol; 2005 Apr; 25(7):2558-72. PubMed ID: 15767663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 4E-BP-eIF4E axis promotes rapamycin-sensitive growth and proliferation in lymphocytes.
    So L; Lee J; Palafox M; Mallya S; Woxland CG; Arguello M; Truitt ML; Sonenberg N; Ruggero D; Fruman DA
    Sci Signal; 2016 May; 9(430):ra57. PubMed ID: 27245614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation dynamics of eukaryotic initiation factor 4E binding protein 1 (4E-BP1) is discordant with its potential to interact with eukaryotic initiation factor 4E (eIF4E).
    Showkat M; Beigh MA; Bhat BB; Batool A; Andrabi KI
    Cell Signal; 2014 Oct; 26(10):2117-21. PubMed ID: 24975846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.